Corporate Banner
Satellite Banner
Scientific Community
Join | Sign in

  News Archive

QIAGEN Expands Leadership in Liquid Biopsies
Tuesday, March 17, 2015
QIAGEN and Tokai Pharmaceuticals to co-develop and commercialize the first regulated CTC-based companion diagnostic to guide treatments in prostate cancer.

Genome-Editing Tool Bolsters Efforts To Thwart 'Deadliest' Animal
Tuesday, March 17, 2015
Researchers at the Fralin Life Sciences Institute have turbocharged a red-hot new technology to make it more efficient to make changes in mosquito genetics.

Horizon to Support Cancer Research UK’s Stratified Medicine Program
Friday, March 13, 2015
Horizon’s Diagnostics division to provide genetically defined, human genomic reference standards.

First Treatment Approved Under EAMS
Friday, March 13, 2015
New immunotherapy (pembrolizumab) made available in the UK for treatment of adults with advanced melanoma.

microRNA’s Role as a Double Agent During Hep C Infection
Friday, March 13, 2015
Study suggests hepatitis C alters gene expression of infected cells by binding to miRNA-122.

Cellular Scissors Chop up HIV Virus
Thursday, March 12, 2015
Salk scientists re-engineered the bacterial defense system CRISPR to recognize HIV inside human cells and destroy the virus, offering a potential new therapy.

MorphoSys and Emergent BioSolutions Initiate Phase 1 Clinical Study
Wednesday, March 11, 2015
Phase 1 study to evaluate the novel oncology immunotherapeutic MOR209/ES414 for prostate cancer.

Genetic Discovery May Help Determine Effectiveness of Huntington’s Disease Treatments
Monday, March 09, 2015
A Boston University School of Medicine study identifies a specific genetic signal that correlates to disease severity.

WGBS Announces Research Collaboration with Leading Canadian Laboratory
Saturday, March 07, 2015
Goal of enabling affordable, large-scale BRCA1 and BRCA2 screening for general population.

<< 7 8 9 10 11 12 13 >>
Showing Results 91 - 100 of 3403

SELECTBIO Market Reports
Go to LabTube
Go to eposters